BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 36440817)

  • 1. Cancer-specific Mortality After Cryoablation vs Heat-based Thermal Ablation in T1a Renal Cell Carcinoma.
    Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
    J Urol; 2023 Jan; 209(1):81-88. PubMed ID: 36440817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comparison of Cryoablation with Heat-Based Thermal Ablation for Treatment of Clinical T1a Renal Cell Carcinoma: A National Cancer Database Study.
    Wu J; Chang J; Bai HX; Su C; Zhang PJ; Karakousis G; Reddy S; Hunt S; Soulen MC; Stavropoulos SW; Zhang Z
    J Vasc Interv Radiol; 2019 Jul; 30(7):1027-1033.e3. PubMed ID: 31176590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-specific Mortality in T1a Renal Cell Carcinoma Treated with Local Tumor Destruction Versus Partial Nephrectomy.
    Sorce G; Hoeh B; Hohenhorst L; Panunzio A; Tappero S; Tian Z; Kokorovic A; Larcher A; Capitanio U; Tilki D; Terrone C; Chun FKH; Antonelli A; Saad F; Shariat SF; Montorsi F; Briganti A; Karakiewicz PI
    Eur Urol Focus; 2023 Jan; 9(1):125-132. PubMed ID: 35918270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Tumor Size on Cancer-Specific Mortality Rate After Local Tumor Ablation in T1a Renal-Cell Carcinoma.
    Palumbo C; Cyr SJ; Mazzone E; Mistretta FA; Knipper S; Pecoraro A; Tian Z; Shariat SF; Saad F; Simeone C; Briganti A; Kapoor A; Antonelli A; Karakiewicz PI
    J Endourol; 2019 Jul; 33(7):606-613. PubMed ID: 30990074
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryoablation Predisposes to Higher Cancer Specific Mortality Relative to Partial Nephrectomy in Patients with Nonmetastatic pT1b Kidney Cancer.
    Pecoraro A; Palumbo C; Knipper S; Mistretta FA; Tian Z; Shariat SF; Saad F; Briganti A; Fiori C; Porpiglia F; Karakiewicz PI
    J Urol; 2019 Dec; 202(6):1120-1126. PubMed ID: 31347950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Body Radiotherapy for Stage I Renal Cell Carcinoma: National Treatment Trends and Outcomes Compared to Partial Nephrectomy and Thermal Ablation.
    Uhlig A; Uhlig J; Trojan L; Kim HS
    J Vasc Interv Radiol; 2020 Apr; 31(4):564-571. PubMed ID: 32127324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency Ablation, Cryoablation, and Microwave Ablation for T1a Renal Cell Carcinoma: A Comparative Evaluation of Therapeutic and Renal Function Outcomes.
    Zhou W; Herwald SE; McCarthy C; Uppot RN; Arellano RS
    J Vasc Interv Radiol; 2019 Jul; 30(7):1035-1042. PubMed ID: 30956075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oncologic Outcomes Following Partial Nephrectomy and Percutaneous Ablation for cT1 Renal Masses.
    Andrews JR; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Aug; 76(2):244-251. PubMed ID: 31060824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal Ablation of T1c Renal Cell Carcinoma: A Comparative Assessment of Technical Performance, Procedural Outcome, and Safety of Microwave Ablation, Radiofrequency Ablation, and Cryoablation.
    Zhou W; Arellano RS
    J Vasc Interv Radiol; 2018 Jul; 29(7):943-951. PubMed ID: 29628298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of iodinated contrast material on post-operative eGFR when administered during renal mass ablation.
    Curci NE; Triche BL; Abel EJ; Bhutani G; Maciolek KA; Dreyfuss LD; Allen GO; Caoili EM; Davenport MS; Wells SA
    Eur Radiol; 2021 Aug; 31(8):5490-5497. PubMed ID: 33492471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial nephrectomy vs cryoablation for T1a renal cell carcinoma: A comparison of survival benefit stratified by tumour size.
    Liao X; Qiu S; Wang W; Zheng X; Jin K; Zhang S; Bao Y; Yang L; Wei Q
    Cancer Epidemiol; 2019 Apr; 59():221-226. PubMed ID: 30836219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of a Risk-stratified Approach for Follow-up Imaging After Percutaneous Thermal Ablation of Sporadic Stage One Renal Cell Carcinoma.
    Dreyfuss LD; Wells SA; Best SL; Hedican SP; Ziemlewicz TJ; Lubner MG; Hinshaw JL; Lee FT; Nakada SY; Abel EJ
    Urology; 2019 Dec; 134():148-153. PubMed ID: 31465794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cryoablation or radiofrequency ablation of the small renal mass : a meta-analysis.
    Kunkle DA; Uzzo RG
    Cancer; 2008 Nov; 113(10):2671-80. PubMed ID: 18816624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for Localized T1a Clear Cell Renal Cell Carcinoma: Survival Benefit for Cryosurgery and Thermal Ablation Compared to Deferred Therapy.
    Uhlig A; Hahn O; Strauss A; Lotz J; Trojan L; Müller-Wille R; Uhlig J
    Cardiovasc Intervent Radiol; 2018 Feb; 41(2):277-283. PubMed ID: 29075878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thermal ablation vs surgery for localized kidney cancer: a Surveillance, Epidemiology, and End Results (SEER) database analysis.
    Choueiri TK; Schutz FA; Hevelone ND; Nguyen PL; Lipsitz SR; Williams SB; Silverman SG; Hu JC
    Urology; 2011 Jul; 78(1):93-8. PubMed ID: 21550636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses.
    Thompson RH; Atwell T; Schmit G; Lohse CM; Kurup AN; Weisbrod A; Psutka SP; Stewart SB; Callstrom MR; Cheville JC; Boorjian SA; Leibovich BC
    Eur Urol; 2015 Feb; 67(2):252-9. PubMed ID: 25108580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous ablation or minimally invasive partial nephrectomy for cT1a renal masses? A propensity score-matched analysis.
    Bianchi L; Chessa F; Piazza P; Ercolino A; Mottaran A; Recenti D; Serra C; Gaudiano C; Cappelli A; Modestino F; Golfieri R; Bertaccini A; Marcelli E; Porreca A; Celia A; Schiavina R
    Int J Urol; 2022 Mar; 29(3):222-228. PubMed ID: 34894001
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment for T1a Renal Cancer Substratified by Size: "Less is More".
    Moskowitz D; Chang J; Ziogas A; Anton-Culver H; Clayman RV
    J Urol; 2016 Oct; 196(4):1000-7. PubMed ID: 27113965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of local tumor ablation and non-interventional management versus partial nephrectomy in T1a renal cell carcinoma.
    Palumbo C; Mistretta FA; Knipper S; Mazzone E; Pecoraro A; Tian Z; Perrotte P; Antonelli A; Montorsi F; Shariat SF; Saad F; Simeone C; Briganti A; Lavallee LT; Karakiewicz PI
    Minerva Urol Nefrol; 2020 Jun; 72(3):350-359. PubMed ID: 31487976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous cryoablation of solitary sporadic renal cell carcinomas.
    Schmit GD; Thompson RH; Kurup AN; Weisbrod AJ; Carter RE; Callstrom MR; Atwell TD
    BJU Int; 2012 Dec; 110(11 Pt B):E526-31. PubMed ID: 22584010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.